|
±³À°°¿¬ (¸ðüžÆÀÇÇÐ) * º» ÇÁ·Î±×·¥Àº Á¦95Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ Çмú´ëȸ ¿¬°è ÇÁ·Î±×·¥ÀÓ.
ÁÂÀå : Á¤ÀºÈ¯ (ÃæºÏÀÇ´ë) |
08:00~08:20 |
Benign gynecologic conditions in pregnancy |
±ÇÇѼº(°Ç±¹ÀÇ´ë) |
|
08:20~08:40 |
Optimal prenatal care |
Á¤ÁøÈÆ(°üµ¿ÀÇ´ë) |
|
08:40~09:00 |
Clinical implications of nuchal translucency |
ÃÖ¼®ÁÖ(¼º±Õ°üÀÇ´ë) |
|
Opening Remarks
|
09:00~09:15 |
Hong Kyun Lee (President, KSOG) Soon-Beom Kang (Chairman of the board, KSOG) |
|
Maternal-Fetal Medicine
Chairperson : Moon Il Park (Hanyang Univ), Keun Young Lee (Hallym Univ) |
09:30~10:00 |
Fetomaternal cell trafficking: does the baby love and heal its mother? |
Diana W. Bianchi (U.S.A) |
|
10:00~10:30 |
Placental development |
¿À¹ÎÁ¤(°í·ÁÀÇ´ë) |
|
10:30~11:00 |
Adult diseases from fetal origin |
ÃÖ±Ô¿¬(¼øõÇâÀÇ´ë) |
|
Gynecologic Oncology
Chairperson : Youn Yeung Hwang (CHA Univ), Hee Sug Ryu (Ajou Univ) |
11:20~11:50 |
VEGF targeted therapy for ovarian cancer |
Robert A. Burger(U.S.A) |
|
11:50~12:20 |
New developing biomarkers in cervical cancer |
±èº´±â(¼º±Õ°üÀÇ´ë) |
|
12:20~12:50 |
The strategy in the management of endometrial cancer |
±è¿µÅ¹(¿ï»êÀÇ´ë) |
|
Luncheon Symposium (Sponsored by Baxter)
Chairperson : Sun Kyoung Lee (KyungHee Univ) |
12:50~13:50 |
Postoperative Adhesions: Clinical Impact and Prevention |
Anthony Adolfo Luciano (U.S.A) |
|
|
Reproductive Endocrinology
Chairperson : Hyoung Moo Park (Chung-Ang Univ)
Byung-Koo Yoon (Sungkyunkwan Univ) |
13:50~14:20 |
Menopausal women's CV Risks management & BP friendly HT (Sponsored by Bayer Schering) |
Peter Collins (U.K.) |
|
14:20~14:50 |
PCOS as a lifetime metabolic disorder |
Á¤Çý¿ø(ÀÌÈÀÇ´ë) |
|
14:50~15:20 |
Biomarkers as new targets for diagnosis and treatment of endometriosis |
Thomas M. D'Hooghe(Belgium) |
|
General Gynecology
Chairperson : Jin Hong Kim (The Catholic Univ of Korea)
Sung Tack Oh (Chonnam Univ) |
15:40~16:10 |
Determining the £¢Menopausal Status£¢ in breast cancer patients |
Patrick Neven(Belgium) |
|
16:10~16:40 |
Adnexal mass in Korean adolescent patients |
ÀÌÅÃÈÄ(°æºÏÀÇ´ë) |
|
16:40~17:10 |
Abnormal pubertal development in Korean adolescent patients |
À̹ÌÈ(Â÷ÀÇ´ë) |
|
±³À°°¿¬ (ºÎÀÎÁ¾¾çÇÐ)
ÁÂÀå : ¹ÚÂù¿ë (°¡ÃµÀÇ´ë) |
08:00~08:20 |
Natural history of HPV infection; The era of HPV vaccine |
±Ç¿ëÀÏ(ÇѸ²ÀÇ´ë) |
|
08:20~08:40 |
Prevention and management of lymphedema in gynecologic cancer patients
|
±è¿ë¹ü(¼¿ïÀÇ´ë) |
|
08:40~09:00 |
Recent managing concepts for old aged women with gynecologic cancer |
¹Úµ¿Ãá(°¡Å縯ÀÇ´ë) |
|
Opening Remarks
|
09:00~09:10 |
Á¦ 95Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ Çмú´ëȸ °³È¸½Ä |
|
|
Àλ縻 |
ÀÌÈ«±Õ(ȸÀå, H-CUBE º´¿ø) °¼ø¹ü(ÀÌ»çÀå, ¼¿ïÀÇ´ë) |
|
Ưº°°¿¬
ÁÂÀå : ¹Ú¿ë¿ø (¿¬¼¼ÀÇ´ë) ÇãÁØ¿ë (°í·ÁÀÇ´ë) |
09:25~09:40 |
Çö ½ÃÁ¡¿¡¼ ¹Ù¶óº» ´ëÇÑ»êºÎÀΰúÇÐȸÀÇ ¹Ì·¡ |
°¼ø¹ü(ÀÌ»çÀå, ¼¿ïÀÇ´ë) |
|
09:40~10:00 |
YAZ in clinical practice : the 3years US experience (ÈÄ¿ø : Bayer Schering)
|
Andrea Rapkin(U.S.A) |
|
ÃÊû°¿¬
ÁÂÀå : ±è¿µÅ¹ (¿ï»êÀÇ´ë), À̺´¼® (¿¬¼¼ÀÇ´ë) |
10:20~10:45 |
Noninvasive prenatal diagnosis using cell-free nucleic acids in maternal blood |
Diana W. Bianchi(U.S.A) |
|
10:45~11:10 |
Ovarian cancer disease control in the 21st century |
Robert A. Burger(U.S.A) |
|
11:10~11:35 |
ESHRE Guidelines for the clinical management of endometriosis |
Thomas M. D'Hooghe (Belgium) |
|
11:35~12:00 |
Anti-oestrogens, the breast, bone and joints |
Patrick Neven(Belgium) |
|
Luncheon Symposium(ÈÄ¿ø: MSD)
ÁÂÀå : ±è¼ºÇÑ (°í½ÅÀÇ´ë) |
|
GARDASIL scientific updates based on KSGOC and WHO guideline |
Yong Man Kim (Univ of Ulsan) |
|
|
±³À°°¿¬(»ý½Ä³»ºÐºñÇÐ)
ÁÂÀå : À̱Լ· (ºÎ»êÀÇ´ë) |
08:00~08:20 |
Abnormal uterine bleeding in adolescent period |
±è¹Ì¶õ(¾ÆÁÖÀÇ´ë) |
|
08:20~08:40 |
HT and risk of cancer |
½ÅÁ¤È£(°í·ÁÀÇ´ë) |
|
08:40~09:00 |
Ovulaton induction and COH regimen in infertility patients |
ÃÖ¿µ½Ä(¿¬¼¼ÀÇ´ë) |
|
ÃÊû°¿¬
ÁÂÀå : ÇѼ¼ÁØ (Á¶¼±ÀÇ´ë) ±èÀåÈí (°¡Å縯ÀÇ´ë) |
09:00~09:20 |
PIBF, a key to successful pregnancy (ÈÄ¿ø : Áß¿ÜÁ¦¾à) |
Julia Szekeres-Bartho (Hungary) |
|
09:20~09:40 |
Clinical guideline for heavy menstrual bleeding (ÈÄ¿ø : Bayer Schering) |
äÈñµ¿ |
|
|
±³À°°¿¬(ÀϹݺÎÀΰúÇÐ)
ÁÂÀå : ·ùöÈñ (ÀüºÏÀÇ´ë) |
10:00~10:20 |
Diagnosis and managment of common endometrial pathology |
Á¶¹®°æ(Àü³²ÀÇ´ë) |
|
10:20~10:40 |
Safety and effectiveness of antiemetics during pregnancy |
±è¼®¿µ(°¡ÃµÀÇ´ë) |
|
10:40~11:00 |
Evaluation and management of intractable vaginitis |
³ª¿ëÁø(ºÎ»êÀÇ´ë) |
|
|
|
|
|
|